Literature DB >> 15714820

[Realgar nano-particles induce apoptosis and necrosis in leukemia cell lines K562 and HL-60].

Ning Ning1, Zuo-fu Peng, Lan Yuan, Bao-di Gou, Tian-lan Zhang, Kui Wang.   

Abstract

OBJECTIVE: To examine the growth-inhibitory, apoptosis- and necrosis-inducing effects of realgar nano-particles (RNP) in human chronic myelogenous leukemia cell line K562 and acute myeloid leukemia cell line HL-60, and to find out the chemical species with efficacy.
METHOD: A "solvent-relay" strategy was used for the preparation of RNP suspension. Cell viability was determined by MTT assay. Cell apoptosis and necrosis were characterized with Annexin V-PI double staining in association with flow cytometry and with morphological examination with Hoechst 33258 staining. Parallel experiments with arsenous acid (H3AsO3), the dominant form of arsenic trioxide in the solution, were conducted for comparison. RESULT: The mean diameter of RNP was 159.0 nm. RNP showed growth-inhibitory effect on both cell lines. The double staining test indicated that RNP induced both apoptosis and necrosis, and this was further confirmed by morphological examination.
CONCLUSION: RNP induced both apoptosis and necrosis in leukemia cell lines K562 and HL-60. Thioarsenite species with both As-O and As-S bonds may be the active intermediates in the RNP.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15714820

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  6 in total

1.  Induction of SiHa cells apoptosis by nanometer realgar suspension and its mechanism.

Authors:  Rong Liu; Demin Pu; Yan Liu; Yanxiang Cheng; Ling Yin; Tian Li; Libo Zhao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-06-19

2.  Effect of solanine on the membrane potential of mitochondria in HepG2 cells and [Ca2+]i in the cells.

Authors:  Shi-Yong Gao; Qiu-Juan Wang; Yu-Bin Ji
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

3.  Effect of size and processing method on the cytotoxicity of realgar nanoparticles in cancer cell lines.

Authors:  Weizhong Zhao; Xun Lu; Yuan Yuan; Changsheng Liu; Baican Yang; Hua Hong; Guoying Wang; Fanyan Zeng
Journal:  Int J Nanomedicine       Date:  2011-08-02

4.  Caveolin-1 contributes to realgar nanoparticle therapy in human chronic myelogenous leukemia K562 cells.

Authors:  Dan Shi; Yan Liu; Ronggang Xi; Wei Zou; Lijun Wu; Zhiran Zhang; Zhongyang Liu; Chao Qu; Baoli Xu; Xiaobo Wang
Journal:  Int J Nanomedicine       Date:  2016-11-07

5.  (-)-Epigallocatechin-3-gallate encapsulated realgar nanoparticles exhibit enhanced anticancer therapeutic efficacy against acute promyelocytic leukemia.

Authors:  Wei Fang; Zhao Liang Peng; Ya Ji Dai; Dian Lei Wang; Peng Huang; He Ping Huang
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

6.  Enhanced antitumor activity of realgar mediated by milling it to nanosize.

Authors:  Ye Tian; Xiaobo Wang; Ronggang Xi; Weisan Pan; Shuang Jiang; Zhao Li; Yu Zhao; Guanghui Gao; Dan Liu
Journal:  Int J Nanomedicine       Date:  2014-01-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.